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Abstract
Background: As the population ages, bioprosthesis are increasingly being used in cardiac valve replacement.
Pericardial bioprosthesis combine an excellent hemodynamic performance with low thrombogenicity, but valve
failure associated with calcification remains a concern with these valves. We describe distortion of the bioprosthesis
ring as a risk factor for early calcification.
Methods: A total of 510 patients over the age of 70 years underwent isolated aortic valve replacement with the
Mitroflow (A12) pericardial bioprosthesis. Thirty two patients (6,2%) have undergone a second aortic valve
replacement due to structural valve dysfunction resulting from valve calcification. In all patients a chest radiography
and coronary angiography was performed before reoperation. A 64 Multidetector Computed Tomography (MDCT)
with retrospective ECG gating study was performed in four patients to evaluate the aortic bioprosthesis.
Results: Chest radiography showed in all patients an irregular bioprosthesis ring. At preoperative coronary
angiography a distorted bioprosthesis ring was detected in all patients. Macroscopic findings of the explanted
bioprostheses included extensive calcification in all specimens.
Conclusion: There was a possible relationship between early bioprosthetic calcification and radiologic distortion of
the bioprosthesis ring.
As the population ages, bioprosthesis are increasingly
being used in cardiac valve replacement. Pericardial bio-
prosthesis combine an excellent hemodynamic perfor-
mance [1] with low thrombogenicity [2], but valve
failure associated with calcification remains a concern
with these valves [3]. We describe distortion of the bio-
prosthesis ring as a risk factor for early calcification.
Materials and methods
A total of 510 patients over the age of 70 years under-
went isolated aortic valve replacement with the Mitro-
flow (A12) pericardial bioprosthesis at our hospital.
Sixty-five percent of patients undergoing aortic valve
replacement received a 21 mm valve. Demographic data
at time of reoperation are listed in Table 1 and the size of
the bioprosthesis in Table 2 To date 32 patients (6,2%)
have undergone a second aortic valve replacement due to
structural valve dysfunction (SVD) resulting from valve
calcification. The mean time between the first operation
and reoperation was 70 months (range 36 to 98 months).
In all patients a chest radiography and coronary angio-
graphy was performed before reoperation.
A 64 Multidetector Computed Tomography (MDCT)
with retrospective ECG gating study was performed in
four patients to evaluate the aortic bioprosthesis. In two
patients the study was performed three weeks after aor-
tic valve replacement with the Mitroflow A12 pericardial
bioprosthesis. Both bioprosthesis were normal by echo-
cardiographic study. Another two patients had bio-
prosthesis with SVD.
A Histopathologic analysis of the removed bioprosth-
esis was performed by one experienced pathologist.
Results
Macroscopic findings of the explanted bioprostheses
included extensive calcification in all specimens. In all
cases, one leaflet was more calcified than the others; in
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the most calcified (19/32. 59,3%).
In all patients, serum levels of cholesterol, triglycerides,
lipoprotein A and calcium were within the normal range.
No patients were treated with calcium supplementation.
Chest radiography (Figure 1) showed in all patients an
irregular, non- circular bioprosthesis ring. At preopera-
tive coronary angiography a distorted bioprosthesis ring
was detected in all patients (Figure 2). An explanted bio-
prosthesis with leaflet distortion and right coronary leaf-
let calcification is shown in Figure 3.
In two patients with normal bioprosthesis, the morphol-
ogy of the leaflets and the degree of excursion were nor-
mal at MDCT, but a leaflet had a wave movement. The
distorted ring was observed in these patients (Figure 4)
and the same picture was observed in two patients with
SVD.
The percentage of distortion of the bioprosthesis ring
in patients without SVD was 76%, but no all patients
had the same degree of distortion.
Discussion
Bioprosthetic calcification is a multifactorial process;
contributing factors include the type of implant used,
mechanical stress, preservation method, patient age and
technical correctness of the implantation procedure [4].
The rate of structural valve dysfunction is lower in
elderly patients and early calcification in this group of
patients is an uncommon event.
There is a strong relationship between mechanical
stress and calcification in bioprosthesis [4,5]; in our study
we noted that early calcification tended to develop in
patients with radiologic distortion of the bioprosthesis
ring. Liao and colleagues [4] observed similar results with
bioprostheses removed from left ventricular assist
devices. Distortion of the bioprosthesis ring may be due
to technical problems at implantation [6] or compression
Table 1 Demographic data
Age (range) 77 ± 4 (71 - 86)
Female/Male 18/14
Aortic Stenosis 28 (87,5%)
Renal insufficiency 0
Hypertension 14 (43,7%)
Diabetes 2 (6,25%)
Table 2 Bioprosthesis size
Valve Size (mm) At reoperation
19 1
21 20
23 10
25 1
Figure 1 Radiographic evaluation showed a misshapen
bioprosthesis ring.
Figure 2 Preoperative coronary angiography showed a
misshapen bioprosthesis ring.
Figure 3 Explanted bioprosthesis with leaflet distorted and
calcification.
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Page 2 of 3around the ring. However we speculate that Dacron ring
traction from the annular stitch may distort the normal
planar geometry of Mitroflow pericardial bioprosthesis,
leading to distortion of the pericardial leaflet mounted
outside the stent and fixed to the Dacron ring, resulting
in a higher mechanical stress.
In our patients other casual relationship was no found.
Conclusion
In our experience there was a possible relationship
between bioprosthetic calcification and radiologic distor-
tion of the bioprosthesis ring.
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Figure 4 Three different views of the bioprosthesis ring at MDCT.
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